Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.30M | -4.99M | -16.93M | -16.93M | -22.47M |
| Total Depreciation and Amortization | 7.14M | -- | -- | -- | 18.21M |
| Total Amortization of Deferred Charges | 113.00K | -- | -- | -- | 269.80K |
| Total Other Non-Cash Items | 11.77M | 763.70K | 11.33M | 11.33M | 9.00M |
| Change in Net Operating Assets | -5.08M | -- | -- | -- | -7.22M |
| Cash from Operations | 2.65M | -4.23M | -5.60M | -5.60M | -2.22M |
| Capital Expenditure | -753.30K | -- | -- | -- | -1.12M |
| Sale of Property, Plant, and Equipment | 217.60K | -- | -- | -- | 11.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 422.90K | -137.90K | -332.30K | -332.30K | 1.07M |
| Cash from Investing | -112.90K | -137.90K | -332.30K | -332.30K | -45.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -72.00K | -- | -- | -- | -6.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | 2.00K | -- | -- | 5.07M |
| Cash from Financing | -10.30K | 300.00 | -- | -- | -264.40K |
| Foreign Exchange rate Adjustments | 797.80K | -494.10K | 7.40K | 7.40K | -453.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.32M | -4.86M | -5.93M | -5.93M | -2.98M |